EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,000 | -16.7% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,200 | +33.3% | 0.00% | – |
| Q3 2022 | $6,000 | – | 900 | -10.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,000 | -33.3% | 0.00% | – |
| Q1 2022 | $2,000 | – | 1,500 | -25.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 2,000 | -60.8% | 0.00% | – |
| Q1 2021 | $1,000 | -85.7% | 5,100 | +24.4% | 0.00% | – |
| Q4 2020 | $7,000 | -77.4% | 4,100 | -53.8% | 0.00% | -100.0% |
| Q3 2020 | $31,000 | +158.3% | 8,880 | +688.6% | 0.00% | – |
| Q1 2017 | $12,000 | -7.7% | 1,126 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | -13.3% | 1,126 | -0.5% | 0.00% | -100.0% |
| Q3 2016 | $15,000 | -34.8% | 1,132 | -4.8% | 0.00% | 0.0% |
| Q2 2016 | $23,000 | +21.1% | 1,189 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $19,000 | – | 1,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 135,848 | $2,024,000 | 6.74% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $11,397,000 | 4.91% |
| Knoll Capital Management, LLC | 350,238 | $5,219,000 | 3.85% |
| 683 Capital Management, LLC | 1,850,000 | $27,565,000 | 3.15% |
| Soleus Capital Management, L.P. | 205,407 | $3,060,000 | 2.95% |
| Broadfin Capital, LLC | 1,236,368 | $18,422,000 | 2.47% |
| P.A.W. CAPITAL CORP | 144,000 | $2,146,000 | 2.29% |
| MANGROVE PARTNERS IM, LLC | 847,284 | $12,625,000 | 1.85% |
| Corriente Advisors, LLC | 203,898 | $3,038,000 | 1.63% |
| Trellus Management Company, LLC | 63,850 | $951,000 | 1.59% |